LMNL(Delisted)
Liminal BioSciences·NASDAQ
--
--(--)
LMNL fundamentals
Liminal BioSciences (LMNL) released its earnings on Mar 20, 2020: revenue was -- (YoY 0.00%), beat estimates; EPS was -- (YoY 0.00%), met estimates.
Revenue / YoY
--
0.00%
EPS / YoY
--
0.00%
Report date
Mar 20, 2020
EPS
Revenue
Revenue & Expenses
LMNL has released its 2023 Q2 earnings report, with revenue of 84.64K, reflecting a YoY change of -30.61%, and net profit of -6.91M, showing a YoY change of -42.84%. The Sankey diagram below clearly presents LMNL's revenue sources and cost distribution.
Key Indicators
Liminal BioSciences (LMNL) key financial stats and ratios, covering profitability, financial health, and leverage.
Liminal BioSciences (LMNL)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
Liminal BioSciences (LMNL)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
Liminal BioSciences (LMNL)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Where does Liminal BioSciences (LMNL) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Track Liminal BioSciences (LMNL) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield
You can ask Aime
No Data
